BATS | ETF
The fund is an actively-managed exchange-traded fund (ETF) that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution (Genomics Revolution Companies).
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| TEM | Tempus AI, Inc. Class A Common Stock | Healthcare | Health Information Services | 10.10% |
| CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 9.48% |
| TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 7.47% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 6.48% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 5.67% |
| RXRX | Recursion Pharmaceuticals Inc | Healthcare | Biotechnology | 5.59% |
| PSNL | Personalis Inc | Healthcare | Diagnostics & Research | 4.37% |
| ADPT | Adaptive Biotechnologies Corp | Healthcare | Biotechnology | 4.21% |
| SDGR | Schrodinger Inc | Healthcare | Health Information Services | 3.95% |
| CDNA | CareDx Inc | Healthcare | Diagnostics & Research | 3.93% |
| TXG | 10X Genomics Inc | Healthcare | Health Information Services | 3.54% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 3.35% |
| BEAM | Beam Therapeutics Inc | Healthcare | Biotechnology | 3.25% |
| VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 3.15% |
| NTLA | Intellia Therapeutics Inc | Healthcare | Biotechnology | 2.69% |
| ABSI | Absci Corp | Healthcare | Biotechnology | 2.65% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 2.45% |
| ARCT | Arcturus Therapeutics Holdings Inc | Healthcare | Biotechnology | 2.12% |
| NRIX | Nurix Therapeutics Inc | Healthcare | Biotechnology | 1.86% |
| MASS | 908 Devices Inc | Healthcare | Medical Devices | 1.74% |